Chief Medical Officer
Dr. Bimal Shah is responsible for Livongo’s strategic clinical product vision, clinical content, and clinical research and analytics. Dr. Shah previously served as the company’s Senior Vice President for Clinical and Strategic Partnerships, where he provided clinical guidance and launched Livongo first cardiovascular product offering, assisted in strategic pursuits, and explored opportunities to expand Livongo’s offerings into other parts of the healthcare market. Prior to Livongo, Dr. Shah was the Service Line Vice President at Premier, Inc for its real-world evidence business. Prior to Premier, Dr. Shah served as an Assistant Professor at Duke University, where he held numerous leadership positions in research programs and clinical administration. Dr. Shah graduated from the University of North Carolina – Chapel Hill with the highest honors and earned both a Doctor of Medicine and Masters in Business Administration from Duke University. Dr. Shah completed his residency in Internal Medicine at Stanford University before finishing a General Cardiology fellowship at Duke University. He is also a member of both the Board of Advisors for the Duke School of Nursing and Board of Visitors for the University of North Carolina – Chapel Hill. Dr. Shah is a practicing cardiologist.